A
Ankur Gulati
Researcher at Imperial College London
Publications - 44
Citations - 4062
Ankur Gulati is an academic researcher from Imperial College London. The author has contributed to research in topics: Dilated cardiomyopathy & Hypertrophic cardiomyopathy. The author has an hindex of 20, co-authored 41 publications receiving 3251 citations. Previous affiliations of Ankur Gulati include National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.
Ankur Gulati,Andrew Jabbour,Tevfik F Ismail,Kaushik Guha,Jahanzaib Khwaja,Sadaf Raza,Kishen Morarji,Tristan D.H. Brown,Nizar Ismail,Marc R. Dweck,Elisa Di Pietro,Michael Roughton,Ricardo Wage,Yousef Daryani,Rory O'Hanlon,Mary N. Sheppard,Francisco Alpendurada,Alexander R. Lyon,Stuart A. Cook,Martin R. Cowie,Ravi Assomull,Dudley J. Pennell,Sanjay K Prasad +22 more
TL;DR: Risk stratification of patients with nonischemic dilated cardiomyopathy is primarily based on left ventricular ejection fraction (LVEF), and superior prognostic factors may improve patient selection for implantable cardioverter-defibrillators (ICDs) and other management decisions.
Journal ArticleDOI
Midwall Fibrosis Is an Independent Predictor of Mortality in Patients With Aortic Stenosis
Marc R. Dweck,Sanjiv Joshi,Timothy Murigu,Francisco Alpendurada,Andrew Jabbour,Giovanni Melina,Winston Banya,Ankur Gulati,Isabelle Roussin,Sadaf Raza,Nishant A. Prasad,Rick Wage,Cesare Quarto,Emiliano Angeloni,Simone Refice,Mary N. Sheppard,Stuart A. Cook,Philip J. Kilner,Dudley J. Pennell,David E. Newby,Raad H. Mohiaddin,John Pepper,Sanjay K Prasad +22 more
TL;DR: Midwall fibrosis was an independent predictor of mortality in patients with moderate and severe aortic stenosis and has incremental prognostic value to ejection fraction and may provide a useful method of risk stratification.
Journal ArticleDOI
The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries.
Ravi Assomull,Jonathan Lyne,Niall G Keenan,Ankur Gulati,Nicholas Bunce,Simon W. Davies,Dudley J. Pennell,Sanjay K Prasad +7 more
TL;DR: CMR is a valuable adjunct to conventional investigations in a diagnostically challenging and important group of patients with troponin-positive chest pain and unobstructed coronary arteries.
Journal ArticleDOI
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease
Angharad M. Roberts,Angharad M. Roberts,James S. Ware,Daniel S. Herman,Daniel S. Herman,Daniel S. Herman,Sebastian Schafer,John Baksi,Alexander G. Bick,Alexander G. Bick,Rachel Buchan,Roddy Walsh,Shibu John,S Wilkinson,Francesco Mazzarotto,Francesco Mazzarotto,Leanne E. Felkin,Leanne E. Felkin,Sungsam Gong,Jacqueline A. L. MacArthur,Fiona Cunningham,Jason Flannick,Jason Flannick,Stacey Gabriel,David Altshuler,David Altshuler,Peter S. Macdonald,Peter S. Macdonald,Peter S. Macdonald,Matthias Heinig,Anne Keogh,Anne Keogh,Anne Keogh,Christopher S. Hayward,Christopher S. Hayward,Christopher S. Hayward,Nicholas R. Banner,Nicholas R. Banner,Dudley J. Pennell,Dudley J. Pennell,Declan P. O'Regan,Tan Ru San,Antonio de Marvao,Timothy J W Dawes,Ankur Gulati,Emma J. Birks,Emma J. Birks,Magdi H. Yacoub,Michael H. Radke,Michael Gotthardt,James G. Wilson,Christopher J. O'Donnell,Sanjay K Prasad,Paul J.R. Barton,Paul J.R. Barton,Diane Fatkin,Diane Fatkin,Diane Fatkin,Norbert Hubner,Norbert Hubner,Jonathan G. Seidman,Christine E. Seidman,Stuart A. Cook +62 more
TL;DR: It is shown that TTNtv is the most common genetic cause of DCM in ambulant patients in the community, identify clinically important manifestations ofTTNtv-positive DCM, and define the penetrance and outcomes of TTNTV in the general population.
Journal ArticleDOI
The Diagnosis and Evaluation of Dilated Cardiomyopathy
TL;DR: Assessment of myocardial fibrosis predicts both risk of sudden cardiac death and likelihood of LV functional recovery, and has significant potential to guide patient selection for cardioverter-defibrillator implantation.